Methyl brevifolin carboxylate is primarily studied for its potential in medicinal applications due to its bioactive properties. It has shown promise in exhibiting antioxidant effects, which can help in reducing oxidative stress in cells, a factor implicated in various chronic diseases. Additionally, research suggests it may possess anti-inflammatory properties, making it a candidate for developing treatments for inflammatory conditions. Its role in inhibiting certain enzymes also points to potential uses in managing diseases where enzyme regulation is crucial, such as in some metabolic disorders. Ongoing studies are exploring its efficacy and safety for therapeutic use, aiming to harness its properties in pharmaceutical formulations.